Literature DB >> 12235534

Effects of serotonin 1A agonist on acute spinal cord injury.

Y Saruhashi1, Y Matsusue, S Hukuda.   

Abstract

STUDY
DESIGN: We evaluated the effects of serotonin (5-HT) agonists on in vitro models of spinal cord compressive injury. Evoked potentials in injured rat spinal cords (n=24) were recorded during perfusion with 5-HT agonists.
OBJECTIVES: To evaluate the therapeutic effects of 5-HT agonists on the recovery of compound action potentials in injured spinal cords.
METHODS: Rat dorsal columns were isolated, placed in a chamber, and injured by extradural compression with a clip. Conducting action potentials were activated by supramaximal constant current electrical stimuli and recorded during perfusion with 5-HT agonists and antagonists.
RESULTS: After inducing compression injuries, mean action potential amplitudes were reduced to 33.9+/-5.4% of the pre-injury level. After 120 min of perfusion with Ringer's solution, the mean amplitudes recovered to 62.8+/-8.4% of the pre-injury level. At a concentration of 100 micro M, perfusion with tandospirone (a 5-HT1A agonist) resulted in a significantly greater recovery of mean action potential amplitudes at 2 h after the injury (86.2+/-6.9% of pre-injury value) as compared with the control Ringer's solution (62.8+/-8.4% of pre-injury value, P<0.05). In contrast, quipazine (a 5-HT2A agonist) accelerated the decrease of amplitude (54.5+/-11.7% of pre-injury value). 5-HT1A and 5-HT2A agonist did not consistently alter latencies of the action potentials.
CONCLUSION: The 5-HT1A receptor agonist was effective for the recovery of spinal action potential amplitudes in a rat spinal cord injury model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235534     DOI: 10.1038/sj.sc.3101331

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  5 in total

1.  The antioxidant effect of beta-Glucan on oxidative stress status in experimental spinal cord injury in rats.

Authors:  Hakan Kayali; M Fatih Ozdag; Serdar Kahraman; Ahmet Aydin; Engin Gonul; Ahmet Sayal; Zeki Odabasi; Erdener Timurkaynak
Journal:  Neurosurg Rev       Date:  2005-04-30       Impact factor: 3.042

Review 2.  Serotonin 1A Receptor Pharmacotherapy and Neuroplasticity in Spinal Cord Injury.

Authors:  Afaf Bajjig; Florence Cayetanot; J Andrew Taylor; Laurence Bodineau; Isabelle Vivodtzev
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-11

3.  Neuromolecular Imaging Shows Temporal Synchrony Patterns between Serotonin and Movement within Neuronal Motor Circuits in the Brain.

Authors:  Patricia A Broderick
Journal:  Brain Sci       Date:  2013-06-21

4.  Repurposing an orally available drug for the treatment of geographic atrophy.

Authors:  Chulbul M Ahmed; Manas R Biswal; Hong Li; Pingyang Han; Cristhian J Ildefonso; Alfred S Lewin
Journal:  Mol Vis       Date:  2016-04-02       Impact factor: 2.367

Review 5.  Update on Clinical Trials in Dry Age-related Macular Degeneration.

Authors:  Ibrahim Taskintuna; M E A Abdalla Elsayed; Patrik Schatz
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.